Australia a key contributor to global commitment to end deadly rheumatic heart disease

May 28, 2018 | Media Release

The World Health Organisation resolution for global action to tackle rheumatic heart disease (RHD) will have significant implications for Australia, which has some of the highest rates of the disease in the world.

Telethon Kids Institute is a founding partner of END RHD, a national alliance against the disease and home to the END RHD Centre of Research Excellence.

Institute Director Professor Jonathan Carapetis said the resolution, passed late Friday night, will give RHD the attention required to eliminate what is mostly a preventable disease.

Rheumatic fever is caused by an abnormal immune reaction to Strep A infection of the skin and throat and, when left untreated, can lead to rheumatic heart disease – in turn causing disability and premature death. It affects 30 million people worldwide.

“This disease disproportionately affects some of the most vulnerable communities around the world, including Aboriginal and Torres Strait Islander communities in Australia,” Professor Carapetis said.


“It’s the most common acquired cardiovascular disease in children and young adults in low resource settings.

“More than any other condition, RHD is emblematic of the health gap between Indigenous and non-Indigenous Australians.”

The resolution was passed at the 71st World Health Assembly in Geneva, attended by delegates from 194 WHO Member States. The commitment aims to consolidate efforts worldwide towards the prevention, control and elimination of RHD.

“This resolution puts RHD front and centre on the global agenda, meaning governments will be compelled to act,” Professor Carapetis said.

“Countries with a high burden of the disease will be required to prioritise the implementation of strategies aimed at prevention and treatment, with countries with a low burden providing support and funding.”

Professor Carapetis said the passing of the resolution on the global stage reflected growing momentum to end RHD in Australia, and followed a February roundtable convened by Indigenous Health Minister Ken Wyatt with END RHD representatives, that resulted in a commitment to develop a roadmap to end the disease in Australia.

Professor Carapetis applauded the Australian Government for playing a leading role in drafting the resolution.

“We look forward to working closely with all relevant ministers and departments on the implementation of a comprehensive, research-backed strategy to end the disease in Australia.”

“With more than 30 years of research behind us, combined with Indigenous leadership and growing political will at home and internationally, we’ve never been in a stronger position to make ending RHD a reality in Australia.”


Catherine Halkon

END RHD Strategy and Policy Officer
T: +61 466 408 209

Kate Harford

END RHD Communications
T: (08) 9489 7660

About rheumatic heart disease

Rheumatic heart disease (RHD) is caused by an abnormal immune reaction to a streptococcal A infection. Susceptible people develop acute rheumatic fever (ARF) after untreated Strep A sore throats, and possibly skin sores. Recurrent episodes of ARF cause permanent damage to heart valves, leading to heart failure, heart rhythm abnormalities and stroke, and all too often death or severe disability in childhood, adolescence or young adulthood.

  • There are more than 250 cases of acute rheumatic fever each year in Australia. Young people aged 5 – 15 years are at highest risk of first episode of ARF.
  • 50-150 people die each year from RHD. Young Aboriginal Australians are 55 times more likely to die of RHD than their non-Indigenous peers. The average age of death from RHD in Aboriginal people is 40 years.